Zobrazeno 1 - 10
of 32
pro vyhledávání: '"S. Magreault"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
Valganciclovir, the ganciclovir prodrug, is an antiviral agent used to prevent cytomegalovirus infection in renal transplant children. Therapeutic drug monitoring is still necessary to ensure optimal therapeutic area under the concentration-time curv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::473baeb2df4854b81600f3eaf588978f
https://doi.org/10.1128/aac.01597-22
https://doi.org/10.1128/aac.01597-22
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valery Elie, S Magreault, G. Deschenes, N Benyoub, A Facchin, Wei Zhao, Thomas Storme, Evelyne Jacqz-Aigrain, A. Maisin
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
BACKGROUND Valganciclovir, the ganciclovir prodrug, is an antiviral agent administered orally to prevent or treat cytomegalovirus infection in solid organ transplant recipients. Dosing regimen of valganciclovir is still controversial in children, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74dbd456c4224ca158a55862a962531d
https://doi.org/10.1128/aac.01192-19
https://doi.org/10.1128/aac.01192-19
Autor:
A, Facchin, V, Elie, N, Benyoub, S, Magreault, A, Maisin, T, Storme, W, Zhao, G, Deschenes, E, Jacqz-Aigrain
Publikováno v:
Antimicrob Agents Chemother
Valganciclovir, the ganciclovir prodrug, is an antiviral agent administered orally to prevent or treat cytomegalovirus infection in solid-organ transplant recipients. The valganciclovir dosing regimen in children is still controversial, as the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df119601ba9176f5a200a0d90b606dd0
https://pubmed.ncbi.nlm.nih.gov/31527022
https://pubmed.ncbi.nlm.nih.gov/31527022
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archives of Disease in Childhood. 104:e29.2-e29
BackgroundGanciclovir and its pro-drug, valganciclovir, are anti-viral drugs used in cytomegalovirus infections treatment in kidney transplanted children. Both present a high pharmacokinetic variability requiring dosage individualization and Therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a78a3c968429118a3ac1610cab940eb
https://doi.org/10.1136/archdischild-2019-esdppp.68
https://doi.org/10.1136/archdischild-2019-esdppp.68
Autor:
N Benyoub, A Facchin, Véronique Baudouin, Anne Maisin, Evelyne Jacqz-Aigrain, S Magreault, Valery Elie
Publikováno v:
Archives of Disease in Childhood. 104:e16.3-e17
BackgroundCytomegalovirus (CMV) infection is a major cause of morbidity in solid organ transplant recipients. Valganciclovir (ValG), prodrug of the antiviral ganciclovir, is used to prevent or treat CMV infection in this population. is controversial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc01b6e80558041cbb45834f08c7bfef
https://doi.org/10.1136/archdischild-2019-esdppp.38
https://doi.org/10.1136/archdischild-2019-esdppp.38
Publikováno v:
Archives of Disease in Childhood. 104:e43.2-e43
BackgroundAntimicrobials are widely used in children but pediatric dose regimens are not always validated, and PK studies, required to validate dosage, are difficult to conduct in children. Low sampling volume limits the number of PK samples drawn pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b37f46117e812e8685dc0d1583284b5c
https://doi.org/10.1136/archdischild-2019-esdppp.101
https://doi.org/10.1136/archdischild-2019-esdppp.101
Publikováno v:
Archives of Disease in Childhood. 104:e63.1-e63
BackgroundMycophenolate mofetil (MMF) is increasingly used in children with systemic lupus erythematosus (SLE). Monitoring of its active metabolite, mycophenolic acid (MPA), is performed for individual dosage adjustment of MMF and is based on determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5906371f00536c84dbbe95475e630270
https://doi.org/10.1136/archdischild-2019-esdppp.146
https://doi.org/10.1136/archdischild-2019-esdppp.146